Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua J Waterfall

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Nature Communications|September 12, 2024
Cellular origin and clonal evolution of human dedifferentiated liposarcomaNadège Gruel, Chloé Quignot, Laëtitia Lesage, et al.
Cell Reports. Medicine|February 21, 2025
Continuous replenishment of the dysfunctional CD8 T cell axis is associated with response to chemoimmunotherapy in advanced breast cancerChristina Metoikidou, Vadim Karnaukhov, Bram Boeckx, et al.
Nature Communications|May 30, 2023
Author Correction: CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomasLeticia Laura Niborski, Paul Gueguen, Mengliang Ye, et al.
Cancer Discovery|April 3, 2021
Splicing Patterns in <i>SF3B1</i>-Mutated Uveal Melanoma Generate Shared Immunogenic Tumor-Specific NeoepitopesJeremy Bigot, Ana I Lalanne, Francesca Lucibello, et al.
Science Translational Medicine|December 26, 2014
Recurrent epimutation of SDHC in gastrointestinal stromal tumorsJ Keith Killian, Markku Miettinen, Robert L Walker, et al.
Nature Communications|June 29, 2022
CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomasLeticia Laura Niborski, Paul Gueguen, Mengliang Ye, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
Evolutionary Routes in Metastatic Uveal Melanomas Depend on <i>MBD4</i> AlterationsManuel Rodrigues, Lenha Mobuchon, Alexandre Houy, et al.
Nature Communications|July 1, 2018
Harnessing synthetic lethality to predict the response to cancer treatmentJoo Sang Lee, Avinash Das, Livnat Jerby-Arnon, et al.
Cell Reports. Medicine|May 23, 2024
Single-cell multiomics profiling reveals heterogeneous transcriptional programs and microenvironment in DSRCTsClémence Henon, Julien Vibert, Thomas Eychenne, et al.
Molecular Cell|May 13, 2022
Oncogenic chimeric transcription factors drive tumor-specific transcription, processing, and translation of silent genomic regionsJulien Vibert, Olivier Saulnier, Céline Collin, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Nature Communications|September 12, 2024
Cellular origin and clonal evolution of human dedifferentiated liposarcomaNadège Gruel, Chloé Quignot, Laëtitia Lesage, et al.
Cell Reports. Medicine|February 21, 2025
Continuous replenishment of the dysfunctional CD8 T cell axis is associated with response to chemoimmunotherapy in advanced breast cancerChristina Metoikidou, Vadim Karnaukhov, Bram Boeckx, et al.
Nature Communications|May 30, 2023
Author Correction: CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomasLeticia Laura Niborski, Paul Gueguen, Mengliang Ye, et al.
Cancer Discovery|April 3, 2021
Splicing Patterns in <i>SF3B1</i>-Mutated Uveal Melanoma Generate Shared Immunogenic Tumor-Specific NeoepitopesJeremy Bigot, Ana I Lalanne, Francesca Lucibello, et al.
Science Translational Medicine|December 26, 2014
Recurrent epimutation of SDHC in gastrointestinal stromal tumorsJ Keith Killian, Markku Miettinen, Robert L Walker, et al.
Nature Communications|June 29, 2022
CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomasLeticia Laura Niborski, Paul Gueguen, Mengliang Ye, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
Evolutionary Routes in Metastatic Uveal Melanomas Depend on <i>MBD4</i> AlterationsManuel Rodrigues, Lenha Mobuchon, Alexandre Houy, et al.
Nature Communications|July 1, 2018
Harnessing synthetic lethality to predict the response to cancer treatmentJoo Sang Lee, Avinash Das, Livnat Jerby-Arnon, et al.
Cell Reports. Medicine|May 23, 2024
Single-cell multiomics profiling reveals heterogeneous transcriptional programs and microenvironment in DSRCTsClémence Henon, Julien Vibert, Thomas Eychenne, et al.
Molecular Cell|May 13, 2022
Oncogenic chimeric transcription factors drive tumor-specific transcription, processing, and translation of silent genomic regionsJulien Vibert, Olivier Saulnier, Céline Collin, et al.
Pageof 7